Ozempic and Eating Disorders: Risks and Safer Alternatives
Ozempic, containing the active ingredient semaglutide, belongs to the GLP-1 (glucagon-like peptide-1) receptor agonist class. It was originally developed for type 2 diabetes management and, in certain cases, medical weight control. However, Ozempic has recently become widely popular on social media as a “quick fix” for weight loss. While this growing trend may sound appealing, […]
Ozempic and Eating Disorders: Risks and Safer Alternatives Read More »